Page 4 - John Haurum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John haurum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Haurum Today - Breaking & Trending Today

Bulletin from the annual general meeting in SynAct Pharma AB on 21 May 2021

Bulletin from the annual general meeting in SynAct Pharma AB on 21 May 2021
Today, on 21 May 2021, the annual general meeting was held in SynAct Pharma AB. In light of the ongoing Covid-19 pandemic and in order to reduce the risk of infection spreading, the annual general meeting was held only by advance voting (postal vote) in accordance with temporary legislation. A summary of the adopted resolutions follows below. All resolutions were adopted with the required majority of votes.
Resolution on adoption of accounts and allocation of the company’s result
Uppdaterad 2021-05-21
Publicerad 2021-05-21
The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet. The annual general meeting also resolved in accordance with the proposal from the board of directors to allocate the company s result, meaning that no di ....

Uli Hacksell , Terje Kalland , Thomas Jonassen , Marina Bozilenko , John Haurum , Bengt Ekenberg , Nomination Committee , Audit Committee , Remuneration Committee , நியமனம் குழு , தணிக்கை குழு ,

Bulletin from the annual general meeting in SynAct Pharma AB on 21 May 2021

Bulletin from the annual general meeting in SynAct Pharma AB on 21 May 2021
di.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from di.se Daily Mail and Mail on Sunday newspapers.

Uli Hacksell , Terje Kalland , Thomas Jonassen , Marina Bozilenko , John Haurum , Bengt Ekenberg , Nomination Committee , Audit Committee , Remuneration Committee , Synact Pharma , நியமனம் குழு , தணிக்கை குழு ,

CatalYm Appoints Industry Leader Dr. Phil L'Huillier as Chief Executive Officer

Share:
MUNICH, Germany, May 04, 2021 (GLOBE NEWSWIRE) CatalYm GmbH, a biopharmaceutical company developing novel cancer immunotherapies, today announced the appointment of Dr. Phil L Huillier as Chief Executive Officer (CEO), effective May 17, 2021. Dr. Phil L Huillier brings over two decades of experience in executive leadership positions in the pharmaceutical and biotechnology industries, with an outstanding track record of success in the commercial development of businesses and partnerships. His experience reflects an international career in business, science, and academia.
Dr. Phil L Huillier joins CatalYm from a position as Head of the European Innovation Hub & Business Development at MSD (known as Merck & Co. in North America). In this position he was an active member of MSD global Business Development and Licensing Leadership as well leading a team of scientific and business development professionals that were focused on the identification, evaluation and develo ....

New Zealand , United States , Katja Arnold , Wachstumsfonds Bayern , Artios Pharma , Shaun Brown , John Haurum , Catalym Gmb , Phil Lhuillier , Joerg Wischhusen , Mc Services , Board Member Of Cancer Research Technology , European Fund For Strategic Investments , Merck Co , European Union , University Of Auckland , Novartis Venture Fund , Business Development , Phill Huillier , Chief Executive Officer , European Innovation Hub , North America , Licensing Leadership , Executive Director , Board Member , Cancer Research Technology ,

CatalYm Appoints Industry Leader Dr. Phil L'Huillier as

MUNICH, Germany, May 04, 2021 (GLOBE NEWSWIRE) CatalYm GmbH, a biopharmaceutical company developing novel cancer immunotherapies, today announced the. ....

New Zealand , United States , Katja Arnold , Wachstumsfonds Bayern , Artios Pharma , Shaun Brown , John Haurum , Catalym Gmb , Phil Lhuillier , Joerg Wischhusen , Mc Services , Board Member Of Cancer Research Technology , European Fund For Strategic Investments , Merck Co , European Union , University Of Auckland , Novartis Venture Fund , Business Development , Phill Huillier , Chief Executive Officer , European Innovation Hub , North America , Licensing Leadership , Executive Director , Board Member , Cancer Research Technology ,

CatalYm Appoints Industry Leader Dr. Phil L'Huillier as Chief Executive Officer

CatalYm Appoints Industry Leader Dr. Phil L'Huillier as Chief Executive Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New Zealand , United States , Catalym Gmb , Wachstumsfonds Bayern , Artios Pharma , Phil Lhuillier , Catalym Gmbham Klopferspitz , Joerg Wischhusen , John Haurum , European Union , Board Member Of Cancer Research Technology , European Fund For Strategic Investments , Merck Co , Novartis Venture Fund , University Of Auckland , Business Development , Phill Huillier , Chief Executive Officer , European Innovation Hub , North America , Licensing Leadership , Executive Director , Board Member , Cancer Research Technology , Non Executive Director , Achilles Therapeutic Artios Pharma ,